IP Library Granted Patent US 9,206,250
Granted Patent B2
US 9,206,250 · App. 13/637,973 · Granted Dec 8, 2015

Monoclonal antibodies and method of immunological analysis of D-dimer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,206,250
App. No.
13/637,973
Granted
Dec 8, 2015
Kind
B2
Abstract

Provided are an antibody capable of specifically and accurately measuring digested products of stabilized fibrin (D-dimer), and a method and a reagent for measuring D-dimer using the antibody. The antibody specifically reacts with D-dimer, which is plasmin-digested products of stabilized fibrin, but does not react with fibrinogen or plasmin-digested products of fibrinogen, which include fragment X, fragment Y, fragment D1, and fragment E3, and does not react with dissociation products of DD/E monomer, which include fragment DD, fragment E1, and fragment E2.

Claims (16)

1. An anti-D-dimer antibody, which specifically reacts with a D-dimer, wherein the D-Dimer is a plasmin digested product of stabilized fibrin, but does not react with (1), (2) and (3) as follows:

(1) Fibrinogen,

(2) fragment X, fragment Y, fragment D1 and fragment E3, which are plasmin-digested products of fibrinogen; and

(3) fragment DD, fragment E1 and fragment E2, which are dissociation products of a DD/E monomer, wherein said DD/E monomer is a basic unit of plasmin-digested products of stabilized fibrin.

2. A functional fragment of the antibody according to claim 1 .

3. A hybridoma which produces the antibody according to claim 1 .

4. A method of immunologically measuring the D-dimer contained in a biological sample, comprising the steps of:

labeling the antibody of claim 1 or a functional fragment thereof with a detectable moiety,

bringing the biological sample into contact with the labeled antibody or fragment to form an immunological complex, and

detecting the detectable moiety from the immunological complex, and

correlating it to a concentration; or

immobilizing the antibody of claim 1 or a functional fragment thereof on a solid phase,

bringing the biological sample into contact with the solid phase carrying the antibody or fragment,

detecting the degree of agglutination, and

correlating it to a concentration.

5. A reagent for immunologically measuring the D-dimer, comprising the antibody according to claim 1 or a functional fragment thereof.

Assignments (4)
CHANGE OF ADDRESS Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 066674/0958 →
COMPANY SPLIT Recorded Feb 25, 2024
From: LSI MEDIENCE CORPORATION
To: PHC CORPORATION
Reel/Frame 066675/0001 →
CHANGE OF NAME Recorded Feb 5, 2015
From: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
To: LSI MEDIENCE CORPORATION
Reel/Frame 034916/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2012
From: NAGAHAMA, YUTAKA; NOZAKI, JUNKO; SAKURAI, GEORGE
To: MITSUBISHI CHEMICAL MEDIENCE CORPORATION
Reel/Frame 029104/0519 →